The companies have presented positive Phase II data during an oral session at IDWeek 2024, in Los Angeles, US.

Gilead has grown to become a leader in the fight against HIV and has announced efforts to improve access to a new, highly ...

Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...

Progress has been made in HIV care. However, that doesn’t mean you don’t need a detailed plan for taking care of an ...

Fostemsavir plus optimized background therapy was associated with improvements in immune biomarkers among HTE patients with MDR HIV infection.

Among recipients with HIV, kidney transplantation from donors with HIV is noninferior to that from donors without HIV.

The national HIV prevalence was 16. 3% among adults aged 15 years and older, translating to an estimated 7. 4 million adults ...

Two posters compared health care resource utilization (HCRU) and financial burdens of people living with HIV with a non-HIV ...

Early on, human immunodeficiency virus (HIV) causes flu-like symptoms, which are similar across sexes. HIV symptoms in women may differ after the initial infection and include changes in menstrual ...

Gilead and Merck & Co. have guided their once-weekly HIV combination therapy past another milestone, linking the cocktail to ...

Keep reading to find out the key distinctions between HIV and AIDS, including symptoms, progression, treatment options, and overall impact on health. Are HIV and AIDS the Same Thing? HIV and AIDS ...

Namibia has made significant strides in stemming the spread of HIV and AIDS through education and prevention. However, for people like Anna Engomba, the arrival of new, life-saving medication cannot ...